Abstract
The relationship between the data obtained from provocative tests and angiographically assessed coronary artery disease is usually expressed in terms of sensitivity and specificity, where sensitivity is the frequency of a positive test result in a population of patients with coronary artery disease and specificity is the frequency of a negative test result in a population of patients without disease. In a given population, sensitivity and specificity values are affected by a constellation of factors (some of which – more relevant to stress echocardiography – are summarized in Tables 19.1 and 19.2) related to the angiographic standard, patient population, stress methodology, and interpretation criteria. In the presence of more severe and extensive coronary artery disease, any stress echocardiography test will give higher sensitivity values [1]. For any given level of stenosis, angiographic coronary lesions of the complex type (i.e., with intraluminal filling defects and/or irregular margins suggestive of thrombus and/or ulcers) will give higher sensitivity values for vasodilator stresses [2], but not inotropic stresses [3]. Abundant coronary collateral circulation makes the myocardium more vulnerable to ischemia during vasodilator stresses [4], whereas exercise or inotropic stress results are independent of angiographically assessed collateral circulation [5]. All stresses yield better sensitivity results in populations with previous myocardial infarction and in patients studied while they are off antianginal therapy, which lowers the sensitivity of both physical and pharmacological stresses [6, 7]. The evaluation of patients with variant angina inflates sensitivity since stresses such as exercise or dobutamine may elicit vasospasm – and therefore ischemia – independently of the underlying organic stenosis. Stress-related factors are also important. Submaximal stresses sharply lower test sensitivity (to a greater extent than perfusion imaging sensitivity) [6]. During exercise, a peak stress acquisition yields better sensitivity than poststress imaging such as the one performed after treadmill exercise. The use of more aggressive test protocols leads to higher sensitivities; however, the user-friendliness of the test declines. For pharmacological tests, the best trade-off between accuracy and feasibility for primary diagnostic purposes is probably a high dose with atropine for dobutamine and an accelerated high dose for dipyridamole (Fig. 19.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Philbrick JT, Horwitz RI, Feinstein AR (1980) Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias. Am J Cardiol 46:807–812
Lu C, Picano E, Pingitore A et al (1995) Complex coronary artery lesion morphology influences results of stress echocardiography. Circulation 91:1669–1675
Heyman J, Salvade P, Picano E et al (1997) The elusive link between coronary lesion morphology and dobutamine stress echocardiography results. The EDIC (Echo Dobutamine International Cooperative) Study Group. Int J Card Imaging 13:395–401
Gliozheni E, Picano E, Bernardino L et al (1996) Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing. Am J Cardiol 78:1419–1424
Beleslin BD, Ostojic M, Djordjevic-Dikic A et al (1999) Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol 33:717–726
Marwick T, Willemart B, D’Hondt AM et al (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87:345–354
Severi S, Picano E, Michelassi C et al (1994) Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 89:1160–1173
Marwick T, D’Hondt AM, Baudhuin T et al (1993) Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 22:159–167
Parodi G, Picano E, Marcassa C, Sicari R et al (1999) High dose dipyridamole myocardial imaging: simultaneous sestamibi scintigraphy and two-dimensional echocardiography in the detection and evaluation of coronary artery disease. Italian Group of Nuclear Cardiology. Coron Artery Dis 10:177–184
Quinones MA, Verani MS, Haichin RM et al (1992) Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients. Circulation 85:1026–1031
de Albuquerque Fonseca L, Picano E (2001) Comparison of dipyridamole and exercise stress echocardiography for detection of coronary artery disease (a meta-analysis). Am J Cardiol 87:1193–1196
Picano E, Molinaro S, Pasanisi E (2008) The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound 6:30
Imran MB, Palinkas A, Picano E (2003) Head-to-head comparison of dipyridamole echocardiography and stress perfusion scintigraphy for the detection of coronary artery disease: a meta-analysis. Comparison between stress echo and scintigraphy. Int J Cardiovasc Imaging 19:23–28
Pingitore A, Picano E, Colosso MQ et al (1996) The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 27:1164–1170
Douglas PS, Khandheria B, Stainback RF et al (2008) ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol 51:1127–1147
Pingitore A, Picano E, Varga A et al (1999) Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 34:1769–1777
Picano E, Ostojic M, Varga A et al (1996) Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 27:1422–1428
Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR (1992) Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 116:190–196
Beleslin BD, Ostojic M, Stepanovic J et al (1994) Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 90:1168–1176
Sochowski RA, Yvorchuk KJ, Yang Y, Rattes MF, Chan KL (1995) Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease. J Am Soc Echocardiogr 8:482–487
Lattanzi F, Picano E, Bolognese L et al (1991) Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise-electrocardiography. Circulation 83:1256–1262
Sicari R, Nihoyannopoulos P, Evangelista A et al (2008) Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 9:415–437
Mor-Avi V, Lang RM, Badano LP et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277–313
Sutherland GR, Di Salvo G, Claus P et al (2004) Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 17:788–802
Reant P, Labrousse L, Lafitte S et al (2008) Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. J Am Coll Cardiol 51:149–157
Edvardsen T, Gerber BL, Garot J et al (2002) Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans – validation against three-dimensional tagged magnetic resonance imaging. Circulation 106:50–56
Voigt JU, Exner B, Schmiedehausen K et al (2003) Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 107:2120–2126
Hanekom L, Cho G-Y, Leano R, Jeffriess L, Marwick TH (2007) Comparison of two-dimensional speckle and tissue Doppler strain measurement during dobutamine stress echocardiography: an angiographic correlation. Eur Heart J 28:1765–1772
Ng ACT, Sitges M, Pham PN et al (2009) Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography. Am Heart J 158:836–844
Yu Y, Villarraga HR, Saleh HK, Cha SS, Pellikka PA (2013) Can ischemia and dyssynchrony be detected during early stages of dobutamine stress echocardiography by 2-dimensional speckle tracking echocardiography? Int J Cardiovasc Imaging 29:95–102
Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH (2010) Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. JACC Cardiovasc Imaging 3:121–131
Leung M, Juergens CP, Lo ST, Leung DY (2014) Evaluation of coronary microvascular function by left ventricular contractile reserve with low-dose dobutamine echocardiography. EuroIntervention 9:1202–1209
Kawasaki M, Abe S, Tanaka R et al (2013) Assessment of coronary artery disease with real time three-dimensional speckle tracking stress echocardiography with adenosine: a comparative study with thallium scintigraphy and coronary angiography. Circulation 128:22–31
Senior R, Becher H, Monaghan M et al (2009) Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 10:194–212
Thomas JD (2013) Myocardial contrast echocardiography perfusion imaging. J Am Coll Cardiol 62:1362–1364
Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM et al (2008) American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21:1179–1201
Dolan MS, Riad K, El-Shafei A, Puri S et al (2001) Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 142:908–915
Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R et al (2008) A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease the OPTIMIZE trial. JACC Cardiovasc Imaging 1:145–152
Jeetley P, Hickman M, Kamp O et al (2006) Myocardial contrast echocardiography for the detection of coronary artery stenosis – a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 47:141–145
Senior R, Moreo A, Gaibazzi N et al (2013) Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease. J Am Coll Cardiol 62:1353–1361
Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D et al (2009) Stress echocardiography expert consensus statement – European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 30:278–289
Yoshitani H, Takeuchi M, Mor-Avi V et al (2009) Comparative diagnostic accuracy of multiplane and multislice three-dimensional dobutamine stress echocardiography in the diagnosis of coronary artery disease. J Am Soc Echocardiogr 22:437–442
Varnero S, Santagata P, Pratali L, Basso M, Gandolfo A, Bellotti P (2008) Head to head comparison of 2D vs real time 3D dipyridamole stress echocardiography. Cardiovasc Ultrasound 6:31
Eroglu E, D’Hooge J, Herbots L et al (2006) Comparison of real-time tri-plane and conventional 2D dobutamine stress echocardiography for the assessment of coronary artery disease. Eur Heart J 27:1719–1724
Lethen H, Tries HP, Zuercher H, Lambertz H (2006) Comparison of real-time three-dimensional bicycle stress echocardiography with conventional two-dimensional bicycle stress echo. Eur Heart J 27:98–104
Jenkins C, Haluska B, Marwick TH (2009) Assessment of temporal heterogeneity and regional motion to identify wall motion abnormalities using treadmill exercise stress three-dimensional echocardiography. J Am Soc Echocardiogr 22:268–275
Takeuchi M, Otani S, Weinert L, Spencer KT, Lang RM (2006) Comparison of contrast-enhanced real-time live 3-dimensional dobutamine stress echocardiography with contrast 2-dimensional echocardiography for detecting stress-induced wall-motion abnormalities. J Am Soc Echocardiogr 19:294–299
Badano LP, Muraru D, Rigo F et al (2010) High volume-rate three-dimensional stress echocardiography to assess inducible myocardial ischemia: a feasibility study. J Am Soc Echocardiogr 23:628–635
Aggeli C, Felekos I, Roussakis G et al (2011) Value of real-time three-dimensional adenosine stress contrast echocardiography in patients with known or suspected coronary artery disease. Eur J Echocardiogr 12:648–655
Ferrara N, Coltorti F, Leosco D et al (1995) Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate. Eur Heart J 16:903–908
Ferrara N, Longobardi G, Nicolino A et al (1992) Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol 70:724–727
Longobardi G, Ferrara N, Leosco D et al (1995) Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia. Am J Cardiol 76:255–258
Fioretti PM, Poldermans D, Salustri A et al (1994) Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 15:355–360
Dodi C, Pingitore A, Sicari R, Bruno G, Cordovil A, Picano E (1997) Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography. Eur Heart J 18:242–247
Gibbons RJ, Balady GJ, Bricker JT et al (2002) ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 40:1531–1540
Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381
Fazel R, Gerber TC, Balter S et al (2014) Approaches to enhancing radiation safety in cardiovascular imaging: a scientific statement from the American Heart Association. Circulation 130:1730–1748
Picano E, Vano E, Rehani MM et al (2014) The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J 35:665–672
Wolk MJ, Bailey SR, Doherty JU et al (2014) ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 63:380–406
Task Force M, Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003
Chou R et al; for the High value care task force of the American College of Physicians (2015) Cardiac screening with electrocardiography, stress echocardiography or myocardial perfusion imaging: advice for high-value care from the American College of Physicians. Ann Intern med 162:438–447
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing
About this chapter
Cite this chapter
Garcia-Fernandez, M.A., Marcos-Alberca, P., Picano, E. (2015). Diagnostic Results and Indications. In: Stress Echocardiography. Springer, Cham. https://doi.org/10.1007/978-3-319-20958-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-20958-6_19
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20957-9
Online ISBN: 978-3-319-20958-6
eBook Packages: MedicineMedicine (R0)